Administration of TSG-6 improves memory after traumatic brain injury in mice

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 86-99

  Watanabe, Jun ^a   Shetty, Ashok K ^a   Hattiangady, Bharathi ^a   Kim, Dong Ki ^a   Foraker, Jessica E ^a   Nishida, Hidetaka ^a   Prockop, Darwin J ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Blood brain barrier; Matrix metalloproteinase; Mesenchymal stem cells; Neutrophils; Traumatic brain injury; TSG 6

Indexed keywords

GELATINASE B; INFLAMMATION MODULATORY PROTEIN; MYELOPEROXIDASE; REGULATOR PROTEIN; TSG 6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CHEMOTAXIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL TEST; FORCED SWIM TEST; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MAZE TEST; MEMBRANE PERMEABILITY; MEMORY; MESENCHYMAL STEM CELL; MESENCHYME CELL; MORRIS WATER MAZE TEST; MOUSE; NEUTROPHIL; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; TRAUMATIC BRAIN INJURY; Y MAZE TEST;

BBB; BLOOD BRAIN BARRIER; CCI; CONTROLLED CORTICAL IMPACT INJURY; DCX; DENTATE GYRUS; DG; DOUBLECORTIN; FORCED SWIM TEST; FST; GCL; GRANULE CELL LAYER; MATRIX METALLOPROTEINASE; MESENCHYMAL STEM CELLS; MMP; MPO; MSCS; MYELOPEROXIDASE; NEUTROPHILS; NOR; NOVEL OBJECT RECOGNITION; NOVELTY SUPPRESSED FEEDING TEST; NSFT; SGZ; SUBGRANULAR ZONE; TBI; TLR; TOLL-LIKE RECEPTOR; TRAUMATIC BRAIN INJURY; TSG-6;

ANIMALS; BRAIN INJURIES; CELL ADHESION MOLECULES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEEDING BEHAVIOR; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MAZE LEARNING; MEMORY DISORDERS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; SWIMMING; VON WILLEBRAND FACTOR;

EID: 84881491489     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.06.017     Document Type: Article

References (64)

1. Baranova N., et al. The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J. Biol. Chem. 2011, 286:25675-25686.
2. Blundell C., et al. Towards a structure for a TSG-6.hyaluronan complex by modeling and NMR spectroscopy: insights into other members of the link module superfamily. J. Biol. Chem. 2005, 280:18189-18201.
3. Browne K., et al. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp. Neurol. 2006, 201:301-307.
4. Cao T.V., et al. Inhibitory effects of TSG-6 link module on leukocyte-endothelial cell interactions in vitro and in vivo. Microcirculation 2004, 11:615-624.
5. Chen X., et al. Glucocorticoids aggravate retrograde memory deficiency associated with traumatic brain injury in rats. J. Neurotrauma 2009, 26:253-260.
6. Choi H., et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 2011, 118:330-338.
7. Chopp M., et al. Plasticity and remodeling of brain. J. Neurol. Sci. 2008, 265:97-101.
8. Colter D.C., et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3213-3218.
9. Coronado V.G., et al. Surveillance for traumatic brain injury-related deaths-United States, 1997-2007. MMWR Surveill. Summ. 2011, 60:1-32.
10. Edwards P., et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6months. Lancet 2005, 365:1957-1959.
11. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Ophthalmology 2000, 107:1224-1226.
12. Foraker J.E., et al. Cross-talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPS-stimulated cocultures: the MSCs are activated to secrete prostaglandin E2. J. Neurochem. 2012, 119:1052-1063.
13. Fülöp C., et al. Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes. Gene 1997, 202:95-102.
14. Getting S.J., et al. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J. Biol. Chem. 2002, 277:51068-51076.
15. Ghajar J. Traumatic brain injury. Lancet 2000, 356:923-929.
16. Gidday J.M., et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. 2005, 289:H558-H568.
17. Hua F., et al. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J. Neuroinflammation 2011, 8:1-14.
18. Kohman R., Rhodes J. Neurogenesis, inflammation and behavior. Brain Behav. Immun. 2013, 27:22-32.
19. Kovesdi E., et al. Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. Front. Neurol. 2012, 3:1-18.
20. Kuznetsova S., et al. The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor. J. Biol. Chem. 2005, 280:30899-30908.
21. Kuznetsova S., et al. TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biol. 2008, 27:201-210.
22. Leali D., et al. Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:696-703.
23. Lee R.H., et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
24. Lin J.C., et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch. Ophthalmol. 2000, 118:1129-1132.
25. Maas A.I.R., et al. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008, 7:728-741.
26. Mahmood A., et al. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 2004, 21:33-39.
27. Mahoney D.J., et al. Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments. J. Biol. Chem. 2005, 280:27044-27055.
28. Masel B., DeWitt D. Traumatic brain injury: a disease process, not an event. J. Neurotrauma 2010, 27:1529-1540.
29. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010, 140:771-776.
30. Menge T., et al. Mesenchymal stem cells regulate blood-brain barrier integrity through timp3 release after traumatic brain injury. Sci. Transl. Med. 2012, 4. (161ra150-161ra150).
31. Mihara Y., et al. Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice. J. Mol. Neurosci. 2011, 43:162-168.
32. Milner C.M., Day A.J. TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci. 2003, 116:1863-1873.
33. Milner C.M., et al. TSG-6: a pluripotent inflammatory mediator?. Biochem. Soc. Trans. 2006, 34:446-450.
34. Moxon-Emre I., Schlichter L.C. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J. Neuropathol. Exp. Neurol. 2011, 70:218-235.
35. Myburgh J., et al. Epidemiology and 12-month outcomes from traumatic brain injury in Australia and New Zealand. J. Neurotrauma 2008, 64:854-862.
36. Nagyeri G., et al. TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin. J. Biol. Chem. 2011, 286:23559-23569.
37. Oh J.Y., et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16875-16880.
38. Ohtaki H., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14638-14643.
39. Parihar V.K., et al. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol. Psychiatry 2011, 16:171-183.
40. Parr A.M., et al. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007, 40:609-619.
41. Pati S., et al. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev. 2011, 20:89-101.
42. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 2007, 82:241-243.
43. Ransohoff R., Brown M. Innate immunity in the central nervous system. J. Clin. Invest. 2012, 122:1164-1171.
44. Rao M.S., Shetty A.K. Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur. J. Neurosci. 2004, 19:234-246.
45. Rao M.S., et al. Newly born cells in the ageing dentate gyrus display normal migration, survival and neuronal fate choice but endure retarded early maturation. Eur. J. Neurosci. 2005, 21:464-476.
46. Rawson R.H. The binding of T-1824 and structurally related diazo dyes by the plasma proteins. Am. J. Physiol. 1942, 138:708-717. (708).
47. Rivest S. The promise of anti-inflammatory therapies for CNS injuries and diseases. Expert. Rev. Neurother. 2011, 11:783-786.
48. Roberts I., et al. Effect of intravenous corticosteroids on death within 14days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
49. Roddy G.W., et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem Cells 2011, 29:1572-1579.
50. Rugg M., et al. Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan. J. Biol. Chem. 2005, 280:25674-25686.
51. Russo I., et al. Effects of neuroinflammation on the regenerative capacity of brain stem cells. J. Neurochem. 2011, 116:947-956.
52. Scavenius C., et al. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase. Biochim. Biophys. Acta 2011, 1814:1624-1630.
53. Schmidt O., et al. Closed head injury-an inflammatory disease?. Brain Res. Rev. 2005, 48:388-399.
54. Sekiya I., et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
55. Szanto S., et al. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis Rheum. 2004, 50:3012-3022.
56. Thau Zuchman O., et al. The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. J. Neurotrauma 2012, 29:375-384.
57. Uccelli A., Prockop D.J. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?. Curr. Opin. Immunol. 2010, 22:768-774.
58. Wang X., et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 2000, 20:7037-7042.
59. Wisniewski H.G., Vilcek J. TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev. 1997, 8:143-156.
60. Wisniewski H., Vilcek J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev. 2004, 15:129-146.
61. Wisniewski H.G., et al. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J. Immunol. 1996, 156:1609-1615.
62. Wolfe M., et al. Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs). Methods Mol. Biol. 2008, 449:3-25.
63. Zhang S., et al. Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex. J. Biol. Chem. 2012, 287:12433-12444.
64. Zietlow R., et al. Human stem cells for CNS repair. Cell Tissue Res. 2008, 331:301-322.